Abstract
Abbreviations:
Akt (protein kinase B), AP-1 (activator protein-1), BDMC (bisdemethoxycurcumin), CDCQ (3-caffeoyl,4-dihydrocaffeoylquinic acid), CGA (chlorogenic acid), DMC (demethoxycurcumin), ECM (extracellular matrix), EGF (epidermal growth factor), EMT (epithelial–mesenchymal transition), ERK (extracellular signal-regulated kinase), FAK (focal adhesion kinase), FGF (fibroblast growth factor), GA (gallic acid), HGF (hepatocyte growth factor), HIF (hypoxia-inducible factors), ICAM (intercellular adhesion molecule), IKK (IkBα kinase), JNK (c-Jun N-terminal kinase), MAPK (mitogen activated protein kinase), MMP (matrix metalloproteinase), MR-3 (3,5,4′-trimethoxy-trans-stilbene), MT-1 MMP (membrane type-1 MMP), NF-κB (nuclear factor-kappaB), p38/MAPK (p38 mitogen-activated protein kinase), PAI (plasminogen activator inhibitor), PI3K (phosphoinositide-3 kinase), PKC (protein kinase C), PMA (phorbol-12-myristate-13-acetate), ROS (reactive oxygen species), TGFβ (transforming growth factor β), TIMP (tissue inhibitor metalloproteinase protein), TNF (tumor necrosis factor), uPA (urokinase plasminogen activator)Keywords
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Cancer Treatment ReviewsPurchase one-time access:
References
- Metastatic inefficiency.Adv Cancer Res. 1990; 54: 159-211
- Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation.Cell. 1991; 64: 327-336
- Intravital imaging of cell movement in tumours.Nat Rev Cancer. 2003; 3: 921-930
- Phenols, and phenolic acids.in: Harborne J.B. Methods in plant biochemistry, Volume 1. Plant Phenolics. Academic Press, London1989: 29-74
- Antioxidants in food and food antioxidants.Nahrung. 2000; 44: 158-163
- Antioxidants in plants and oleaginous seeds.in: Morello M.J. Shahidi F. Ho C.T. Free radicals in food: chemistry, nutrition, and health effects. ACS Symposium Series 807 Washington. American Chemical Society, DC2002 (p. 162–75)
- Suppression of cancer invasiveness by dietary compounds.Mini Rev Med Chem. 2008; 8: 677-688
- Molecular basis of tumor metastasis.in: Lemoine N.R. Wright N.A. The molecular pathology of cancer. Cold Spring Harbor Laboratory, Plainview NY1993: 175-199
- Tumour invasion and the extracellular matrix.Lab Invest. 1983; 49: 636-649
- VEGFR1-positive haematopoietic bone marrow progenitors initiate the premetastatic niche.Nature. 2005; 438: 820-827
- General mechanisms of metastasis.Cancer. 1997; 80: 529-537
- Epithelial–mesenchymal transitions in tumour progression.Nat Rev Cancer. 2002; 2: 442-454
- New signals from the invasive front.Nature. 2006; 441: 444-450
- Epithelial–mesenchymal transition: at the crossroads of development and tumor metastasis.Dev Cell. 2008; 14: 818-829
- Expression profiling of epithelial plasticity in tumor progression.Oncogene. 2003; 22: 7155-7169
- Adhesion-independent mechanism for suppression of tumor cell invasion by E-cadherin.J Cell Biol. 2003; 161: 1191-1203
- N-cadherin expression and epithelial–mesenchymal transition in pancreatic carcinoma.Clin Cancer Res. 2004; 10: 4125-4133
- NF-kappaB is essential for epithelial–mesenchymal transition and metastasis in a model of breast cancer progression.J Clin Invest. 2004; 114: 569-581
- TGFbeta in Cancer.Cell. 2008; 134: 215-230
- Molecular requirements for epithelial–mesenchymal transition during tumor progression.Curr Opin Cell Biol. 2005; 17: 548-558
- The transcription factor snail is a repressor of E-cadherin gene expression in epithelial tumour cells.Nat Cell Biol. 2000; 2: 84-89
- The transcription factor snail controls epithelial–mesenchymal transitions by repressing E-cadherin expression.Nat Cell Biol. 2000; 2: 76-83
- The two-handed E box binding zinc finger protein SIP1 downregulates E-cadherin and induces invasion.Mol Cell. 2001; 7: 1267-1278
- Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis.Cell. 2004; 117: 927-939
- DeltaEF1 is a transcriptional repressor of E-cadherin and regulates epithelial plasticity in breast cancer cells.Oncogene. 2005; 24: 2375-2385
- Role of integrins in cell invasion and migration.Nat Rev Cancer. 2002; 2: 91-99
- Tumour-cell invasion and migration: diversity and escape mechanisms.Nat Rev Cancer. 2003; 3: 362-374
- Integrin signalling during tumour progression.Nat Rev Mol Cell Biol. 2004; 5: 816-826
- Cofilin promotes actin polymerization and defines the direction of cell motility.Science. 2004; 304: 743-746
- Cellular motility driven by assembly and disassembly of actin filaments.Cell. 2003; 112: 453-465
- The cofilin pathway in breast cancer invasion and metastasis.Nat Rev Cancer. 2007; 7: 429-440
- Comparative oncogenomics identifies NEDD9 as a melanoma metastasis gene.Cell. 2006; 125: 1269-1281
- Rac activation and inactivation control plasticity of tumor cell movement.Cell. 2008; 135: 510-523
- Spheroids and cell survival.Crit Rev Oncol Hematol. 2000; 36: 61-74
- Tumorinvasion in the absence of epithelial–mesenchymal transition: podoplaninmediated remodeling of the actin cytoskeleton.Cancer Cell. 2006; 9: 261-272
- CD44: from adhesion molecules to signaling regulators.Nat Rev Mol Cell Biol. 2003; 4: 33-45
- Cell adhesion and signalling by cadherins and Ig-CAMs in cancer.Nat Rev Cancer. 2004; 4: 118-132
- Molecular mechanisms of metastasis.Cancer Lett. 2008; 270: 181-190
- Matrix metalloproteinases and metastasis.Cancer Chemother Pharmacol. 1999; 43: S41-S51
- Regulation of matrix metalloproteinase expression in tumor invasion.FASEB J. 1999; 13: 781-792
- Molecular mechanisms of glioma invasiveness: the role of proteases.Nat Rev Cancer. 2003; 3: 489-501
- Matrix metalloproteinases as stromal effectors of human carcinoma progression: therapeutic implications.Matrix Biol. 1997; 15: 535-541
- Matrix metalloproteinases: biologic activity and clinical implications.J Clin Oncol. 2000; 18: 1135-1149
- Enhanced expression of matrix metalloproteinase-9 by hepatitis B virus infection in liver cells.Arch Biochem Biophys. 2002; 408: 147-154
- The urokinase plasminogen activator receptor (uPAR) as a target for the diagnosis and therapy of cancer.Anticancer Drugs. 2001; 12: 387-400
- Ganoderma lucidum suppresses motility of highly invasive breast and prostate cancer cells.Biochem Biophys Res Commun. 2002; 298: 603-612
- UPAR: a versatile signalling orchestrator.Nat Rev Mol Cell Biol. 2002; 3: 932-943
- The urokinase plasminogen activator system in cancer: recent advances and implication for prognosis and therapy.Cancer Metastasis Rev. 2003; 22: 205-222
- Urokinase-type plasminogen activator system and breast cancer (Review).Oncol Rep. 2005; 14: 105-112
- Plasminogen activator inhibitor-1 as a potential marker for the malignancy of colorectal cancer.Br J Cancer. 2005; 93: 799-803
- Plasminogen activator inhibitor type 2 in breast cancer.Br J Cancer. 1997; 76: 622-627
- Urokinase plasminogen activator and its inhibitor PAI-1, in association with progression-free survival in early stage endometrial cancer.Eur J Cancer. 2001; 37: 2339-2348
- MMP-9 and MMP-2 gelatinases and TIMP-1 and TIMP-2 inhibitors in breast cancer: correlations with prognostic factors.J Cell Mol Med. 2006; 10: 499-510
- Regulatory mechanism of 92 kDa type IV collagenase gene expression which is associated with invasiveness of tumor cells.Oncogene. 1993; 8: 395-405
- Identification of a p65 peptide that selectively inhibits NF-kappa B activation induced by various inflammatory stimuli and its role in down-regulation of NF-kappa B-mediated gene expression and up-regulation of apoptosis.J Biol Chem. 2004; 279: 15096-15104
- Kalopanaxsaponin A inhibits PMA-induced invasion by reducing matrix metalloproteinase-9 via PI3K/Akt- and PKCdelta-mediated signaling in MCF-7 human breast cancer cells.Carcinogenesis. 2009; 30: 1225-1233
- Induction of myofibroblast MMP-9 transcription in three-dimensional collagen I gel cultures: regulation by NF-kappaB, AP-1 and Sp1.Int J Biochem Cell Biol. 2004; 36: 353-363
- Regulation of 92-kDa type IV collagenase expression by the jun aminoterminal kinase and the extracellular signal-regulated kinase-dependent signaling cascades.Oncogene. 1997; 14: 1481-1493
- Regulation of protein kinase C.Curr Opin Cell Biol. 1997; 9: 161-167
- Role of ERK and JNK pathways in regulating cell motility and matrix metalloproteinase 9 production in growth factor-stimulated human epidermal keratinocytes.J Cell Physiol. 1999; 180: 271-284
- Induction of MMP-9 in normal human bronchial epithelial cells by TNF- via NF-kB-mediated pathway.Am J Physiol Lung Cell Mol Physiol. 2001; 281: L1444-L1452
- Activation of NF-kB, AP-1, and STAT transcription factors is a frequent and early event in human hepatocellular carcinomas.J Hepatol. 2002; 37: 63-71
- Mathematical modelling of dynamic adaptive tumour-induced angiogenesis: clinical implications and therapeutic targeting strategies.J Theor Biol. 2006; 241: 564-589
- Tumorigenesis and the angiogenic switch.Nat Rev Cancer. 2003; 3: 401-410
- Basement membranes: structure, assembly and role in tumour angiogenesis.Nat Rev Cancer. 2003; 3: 422-433
- Hypoxia – a key regulatory factor in tumour growth.Nat Rev Cancer. 2002; 2: 38-47
- Hypoxia-driven selection of the metastatic phenotype.Cancer Metastasis Rev. 2007; 26: 319-331
- Targeting HIF-1 for cancer therapy.Nat Rev Cancer. 2003; 3: 721-732
- Chemokine receptor CXCR4 downregulated by von Hippel–Lindau tumour suppressor pVHL.Nature. 2003; 425: 307-311
- Hypoxia promotes fibrogenesis in vivo via HIF-1 stimulation of epithelial-to mesenchymal transition.J Clin Invest. 2007; 117: 3810-3820
- Hypoxia attenuates the expression of E-cadherin via up-regulation of SNAIL in ovarian carcinoma cells.Am J Pathol. 2003; 163: 1437-1447
- Hypoxia-inducible factor-1-dependent repression of E-cadherin in von Hippel–Lindau tumor suppressor-null renal cell carcinoma mediated by TCF3, ZFHX1A, and ZFHX1B.Cancer Res. 2006; 66: 2725-2731
- VHL promotes E2 box-dependent E-cadherin transcription by HIF-mediated regulation of SIP1 and snail.Mol Cell Biol. 2007; 27: 157-169
- Direct regulation of TWIST by HIF-1alpha promotes metastasis.Nat Cell Biol. 2008; 10: 295-305
Fuchs E. Das Sarcom des Uvealtractus. In: Braumueller W, editor. Metastasenbildung. Wien: Wilhelm Braumuller;1882; p. 197–206.
- The distribution of secondary growths in cancer of the breast.Lancet. 1889; 1: 571-573
- The pathogenesis of cancer metastasis: the ‘seed and soil’ hypothesis revisited.Nat Rev Cancer. 2003; 3: 453-458
- An address system in the vasculature of normal tissues and tumors.Annu Rev Immunol. 2000; 18: 813-827
- Metadherin, a cell surface protein in breast tumors that mediates lung metastasis.Cancer Cell. 2004; 5: 365-374
- Involvement of chemokine receptors in breast cancer metastasis.Nature. 2001; 410: 50-56
- Curcumin inhibits SK-Hep-1 hepatocellular carcinoma cell invasion in vitro and suppresses matrix metalloproteinase-9 secretion.Oncology. 1998; 55: 349-353
- Prevention of intrahepatic metastasis by curcumin in an orthotopic implantation model.Oncology. 2003; 65: 250-258
- Inhibitory effect of curcumin on the invasion of rat ascites hepatoma cells in vitro and ex vivo.Cytotechnology. 2001; 35: 57-63
- Curcumin inhibits the migration and invasion of human A549 lung cancer cells through the inhibition of matrix metalloproteinase-2 and -9 and Vascular Endothelial Growth Factor (VEGF).Cancer Lett. 2009; 285: 127-133
- Anti-invasive gene expression profile of curcumin in lung adenocarcinoma based on a high throughput microarray analysis.Mol Pharmacol. 2004; 65: 99-110
- Curcumin inhibits lung cancer cell invasion and metastasis through the tumor suppressor HLJ1.Cancer Res. 2008; 68: 7428-7438
- Curcumin exerts multiple suppressive effects on human breast carcinoma cells.Int J Cancer. 2002; 98: 234-240
- The chemopreventive polyphenol Curcumin prevents hematogenous breast cancer metastases in immunodeficient mice.Cell Physiol Biochem. 2007; 19: 137-152
- Curcumin blocks RON tyrosine kinase-mediated invasion of breast carcinoma cells.Cancer Res. 2008; 68: 5185-5192
- Demethoxycurcumin suppresses migration and invasion of MDA-MB-231 human breast cancer cell line.Eur J Pharmacol. 2010; 627: 8-15
- Curcumin inhibition of integrin (alpha6beta4)-dependent breast cancer cell motility and invasion.Cancer Prev Res. 2008; 1: 385-391
- Curcumin suppresses the paclitaxel-induced nuclear factor-kappaB pathway in breast cancer cells and inhibits lung metastasis of human breast cancer in nude mice.Clin Cancer Res. 2005; 11: 7490-7498
- Expression analysis of maspin in invasive ductal carcinoma of breast and modulation of its expression by curcumin in breast cancer cell lines.Chem Biol Interact. 2010; 183: 455-461
- Curcumin inhibits cell motility and alters microfilament organization and function in prostate cancer cells.Cell Motil Cytoskel. 2004; 58: 253-268
- Curcumin blocks CCL2-induced adhesion, motility and invasion, in part, through down-regulation of CCL2 expression and proteolytic activity.Int J Oncol. 2009; 34: 1319-1327
- The effects of curcumin on the invasiveness of prostate cancer in vitro and in vivo.Prostate Cancer Prostatic Dis. 2006; 9: 147-152
- Curcumin, a potential inhibitor of MMP-2 in human laryngeal squamous carcinoma cells HEp2.J Environ Pathol Toxicol Oncol. 2006; 25: 679-690
- Curcumin inhibits neurotensin-mediated interleukin-8 production and migration of HCT116 human colon cancer cells.Clin Cancer Res. 2006; 12: 5346-5355
- Curcumin inhibits cell migration of human colon cancer colo 205 cells through the inhibition of nuclear factor kappa B/p65 and down-regulates cyclooxygenase-2 and matrix metalloproteinase-2 expressions.Anticancer Res. 2006; 26: 1281-1288
- Tetrahydrocurcumin inhibits HT1080 cell migration and invasion via downregulation of MMPs and uPA.Acta Pharmacol Sin. 2008; 29: 853-860
- Curcumin, demethoxycurcumin and bisdemethoxycurcumin differentially inhibit cancer cell invasion through the down-regulation of MMPs and uPA.J Nutr Biochem. 2009; 20: 87-95
- Anti-metastatic activity of curcumin and catechin.Cancer Lett. 1999; 141: 159-165
- Osteopontin induces nuclear factor kappa B-mediated promatrix metalloproteinase-2 activation through I kappa B alpha/IKK signaling pathways, and curcumin (diferulolylmethane) down-regulates these pathways.J Biol Chem. 2003; 278: 14487-14497
- Matrix metalloproteinase-2: mechanism and regulation of NF-kappaB-mediated activation and its role in cell motility and ECM-invasion.Glycoconj J. 2004; 21: 429-441
- Curcumin suppresses proliferation and invasion in human gastric cancer cells by downregulation of PAK1 activity and cyclin D1 expression.Cancer Biol Ther. 2009; 8: 1360-1368
- Effect of curcumin on invasion and migration of tongue squamous cell carcinoma cell line Tca8113.Zhonghua Kou Qiang Yi Xue Za Zhi. 2008; 43: 101-104
- Inhibitory effect of curcumin on motility of human oral squamous carcinoma YD-10B cells via suppression of ERK and NF-kappaB activations.Phytother Res. 2010; 24: 577-582
- Curcumin is a potent broad spectrum inhibitor of matrix metalloproteinase gene expression in human astroglioma cells.Biochem Biophys Res Commun. 2005; 337: 510-516
- Curcumin suppresses phorbol ester-induced matrix metalloproteinase-9 expression by inhibiting the PKC to MAPK signaling pathways in human astroglioma cells.Biochem Biophys Res Commun. 2005; 335: 1017-1025
- Expression of the constitutively activated RelA/NF-kappaB in human astrocytic tumors and the in vitro implication in the regulation of urokinase-type plasminogen activator, migration, and invasion.Brain Tumor Pathol. 2005; 22: 79-87
- Curcumin inhibits tumor growth and angiogenesis in glioblastoma xenografts.Mol Nutr Food Res. 2010; 54: 1192-1201
- Antitumor activity of natural compounds, curcumin and PKF118-310, as Wnt/beta-catenin antagonists against human osteosarcoma cells.Invest New Drugs. 2010; 28: 766-782
- Lysophosphatidic acid induces STAT3 phosphorylation and ovarian cancer cell motility: their inhibition by curcumin.Cancer Lett. 2010; 288: 50-56
- Therapeutic potential of resveratrol: the in vivo evidence.Nat Rev Drug Discov. 2006; 5: 493-506
- Resveratrol downregulates the constitutional activation of nuclear factor-kappaB in multiple myeloma cells, leading to suppression of proliferation and invasion, arrest of cell cycle, and induction of apoptosis.Cancer Genet Cytogenet. 2006; 165: 9-19
- Resveratrol inhibits hypoxia-induced metastasis potential enhancement by restricting hypoxia-induced factor-1 alpha expression in colon carcinoma cells.Biomed Pharmacother. 2008; 62: 613-621
- Resveratrol suppresses hepatoma cell invasion independently of its anti-proliferative action.Cancer Lett. 2001; 167: 151-156
- Resveratrol inhibits hepatoma cell invasion by suppressing gene expression of hepatocyte growth factor via its reactive oxygen species-scavenging property.Clin Exp Metastasis. 2004; 21: 445-451
- Resveratrol inhibits tumor necrosis factor-alpha-mediated matrix metalloproteinase-9 expression and invasion of human hepatocellular carcinoma cells.Biomed Pharmacother. 2008; 62: 366-372
- Effects of resveratrol on matrix metalloproteinase-9 expression in hepatoma cells.Zhong Xi Yi Jie He Xue Bao. 2008; 6: 270-273
- Evaluation of anti-invasion effect of resveratrol and related methoxy analogues on human hepatocarcinoma cells.J Agric Food Chem. 2010; 58: 2886-2894
- Pterostilbene inhibited tumor invasion via suppressing multiple signal transduction pathways in human hepatocellular carcinoma cells.Carcinogenesis. 2009; 30: 1234-1242
- Resveratrol isolated from Polygonum cuspidatum root prevents tumor growth and metastasis to lung and tumor-induced neovascularization in Lewis lung carcinoma-bearing mice.J Nutr. 2001; 131: 1844-1849
- Resveratrol, a natural diphenol, reduces metastatic growth in an experimental cancer model.Cancer Lett. 2007; 245: 144-148
- Resveratrol inhibits human lung adenocarcinoma cell metastasis by suppressing heme oxygenase 1-mediated nuclear factor-kappaB pathway and subsequently downregulating expression of matrix metalloproteinases.Mol Nutr Food Res. 2010; 54: S196-204
- Resveratrol inhibits EGF-induced invasion of human lung adenocarcinoma A549 cells.Zhongguo Fei Ai Za Zhi. 2010; 13: 287-291
- Resveratrol analog-3,5,4′-trimethoxy-trans-stilbene inhibits invasion of human lung adeno-carcinoma cells by suppressing the MAPK pathway and decreasing matrix metalloproteinase-2 expression.Mol Nutr Food Res. 2009; 53: 407-416
- Resveratrol and estradiol exert disparate effects on cell migration, cell surface actin structures, and focal adhesion assembly in MDA-MB-231 human breast cancer cells.Neoplasia. 2005; 7: 128-140
- Resveratrol inhibits heregulin-beta1-mediated matrix metalloproteinase-9 expression and cell invasion in human breast cancer cells.J Nutr Biochem. 2008; 19: 287-294
Pan MH, Lin YT, Lin CL, Wei CS, Ho CT, Chen WJ. Suppression of heregulin-{beta}1/HER2-modulated invasive and aggressive phenotype of breast carcinoma by pterostilbene via inhibition of matrix metalloproteinase-9, p38 kinase cascade and Akt activation. Evid Based Complement Alternat Med [in press].
- The cancer chemopreventive agent resveratrol induces tensin, a cell–matrix adhesion protein with signaling and antitumor activities.Oncogene. 2005; 24: 3274-3284
- Resveratrol inhibits migration and invasion of human breast-cancer cells.Mol Nutr Food Res. 2008; 52: 683-691
- Polyphenols prevent cell shedding from mouse mammary cancer spheroids and inhibit cancer cell invasion in confrontation cultures derived from embryonic stem cells.Cancer Lett. 2007; 250: 25-35
- Effect of resveratrol on matrix metalloproteinase-2 (MMP-2) and Secreted Protein Acidic and Rich in Cysteine (SPARC) on human cultured glioblastoma cells.Biomed Pharmacother. 2005; 59: 359-364
- Inhibition of cancer growth by resveratrol is related to its low bioavailability.Free Radic Biol Med. 2002; 33: 387-398
- Association between pterostilbene and quercetin inhibits metastatic activity of B16 melanoma.Neoplasia. 2005; 7: 37-47
- Study on the effect of resveratrol on metastasis-associated ability of ovarian carcinoma HO-8910PM cells in vitro.Zhong Yao Cai. 2007; 30: 176-178
- Hypoxia enhances LPA-induced HIF-1alpha and VEGF expression: their inhibition by resveratrol.Cancer Lett. 2007; 258: 63-69
- Oral administration of resveratrol in suppression of pulmonary metastasis of BALB/c mice challenged with CT26 colorectal adenocarcinoma cells.Mol Nutr Food Res. 2010; 54: 259-267
- Resveratrol inhibits tumor cell adhesion to endothelial cells by blocking ICAM-1 expression.Anticancer Res. 2009; 29: 355-362
- Resveratrol as a novel agent for treatment of multiple myeloma with matrix metalloproteinase inhibitory activity.Acta Pharmacol Sin. 2006; 27: 1447-1452
- Antiangiogenic and vascular-targeting activity of the microtubule-destabilizing trans-resveratrol derivative 3,5,4′-tri-methoxystilbene.Mol Pharmacol. 2005; 67: 1451-1459
- Alphavbeta3 integrin-dependent antiangiogenic activity of resveratrol stereoisomers.Mol Cancer Ther. 2008; 7: 3761-3770
- Anti-metastasis effects of gallic acid on gastric cancer cells involves inhibition of NF-kappaB activity and downregulation of PI3K/AKT/small GTPase signals.Food Chem Toxicol. 2010; 48: 2508-2516
- Cytotoxic activity of gallic acid against liver metastasis of mastocytoma cells P-815.Anticancer Res. 2001; 21: 3875-3880
- Gallic acid suppresses cell viability, proliferation, invasion and angiogenesis in human glioma cells.Eur J Pharmacol. 2010; 641: 102-107
- Inhibitory effects of chlorogenic acid and its related compounds on the invasion of hepatoma cells in culture.Cytotechnology. 2000; 33: 229-235
- A phenolic compound, 5-caffeoylquinic acid (chlorogenic acid), is a new type and strong matrix metalloproteinase-9 inhibitor: isolation and identification from methanol extract of Euonymus alatus.Life Sci. 2005; 77: 2760-2769
- The chemopreventive properties of chlorogenic acid reveal a potential new role for the microsomal glucose-6-phosphate translocase in brain tumor progression.Cancer Cell Int. 2006; 6: 7
- 3-Caffeoyl, 4-dihydrocaffeoylquinic acid from Salicornia herbacea inhibits tumor cell invasion by regulating protein kinase C-delta-dependent matrix metalloproteinase-9 expression.Toxicol Lett. 2010; 198: 200-209
- Preferential cytotoxicity on tumor cells by caffeic acid phenethyl ester isolated from propolis.Experientia. 1988; 44: 230-232
- Selective antiproliferative activity of caffeic acid phenethyl ester analogues on highly liver-metastatic murine colon 26–L5 carcinoma cell line.Bioorg Med Chem. 2002; 10: 3351-3359
- Novel and therapeutic effect of caffeic acid and caffeic acid phenyl ester on hepatocarcinoma cells: complete regression of hepatoma growth and metastasis by dual mechanism.FASEB J. 2004; 18: 1670-1681
- Caffeic acid phenethyl ester inhibits invasion and expression of matrix metalloproteinase in SK-Hep1 human hepatocellular carcinoma cells by targeting nuclear factor kappa B.Genes Nutr. 2008; 2: 319-322
- Pomegranate (Punica granatum) pure chemicals show possible synergistic inhibition of human PC-3 prostate cancer cell invasion across Matrigel.Invest New Drugs. 2005; 23: 121-122
- Inhibitory effect of caffeic acid phenethyl ester on angiogenesis, tumor invasion, and metastasis.J Agric Food Chem. 2003; 51: 7907-7912
- Inhibitory effects of caffeic acid phenethyl ester on cancer cell metastasis mediated by the down-regulation of matrix metalloproteinase expression in human HT1080 fibrosarcoma cells.J Nutr Biochem. 2006; 17: 356-362
- Carnosol inhibits the invasion of B16/F10 mouse melanoma cells by suppressing metalloproteinase-9 through down-regulating nuclear factor-kappa B and c-Jun.Biochem Pharmacol. 2005; 69: 221-232
- Inhibitory effect of capsaicin on B16–F10 melanoma cell migration via the phosphatidylinositol 3-kinase/Akt/Rac1 signal pathway.Exp Mol Med. 2008; 40: 486-494
- Anti-invasion effects of 6-shogaol and 6-gingerol, two active components in ginger, on human hepatocarcinoma cells.Mol Nutr Food Res. 2010; 54: 1618-1627
- Inhibitory effect of gingerol on the proliferation and invasion of hepatoma cells in culture.Cytotechnology. 2008; 57: 129-136
- 6-Gingerol inhibits metastasis of MDA-MB-231 human breast cancer cells.J Nutr Biochem. 2008; 19: 313-319
- [6-Gingerol, a pungent ingredient of ginger, inhibits angiogenesis in vitro and in vivo.Biochem Biophys Res Commun. 2005; 335: 300-308